Human Genome Project Information. Click to return to home page.

Sponsored by the U.S. Department of Energy Human Genome Program

Human Genome News Archive Edition
Vol.9, No.3   July 1998

In this issue... 

Also available in pdf.

1997 Santa Fe Highlights

Human Genome Project Administration

In the News

Publications

Software and the Internet

Funding

Meeting Calendars & Acronyms

  • Genome and Biotechnology Meetings 
  • Training Courses and Workshops 
  • Acronyms

HGN archives and subscriptions   
HGP Information home 

Sickle Cell Mice May Lead to New Treatments

Genetically engineered mice that mimic all the symptoms of human sickle cell disease were developed by a team led by Edward Rubin and Chris Paszty at LBNL (Science, October 31, 1997). This new mouse strain, which carries human hemoglobin with no counteracting mouse genes, provides a means for effective testing of experimental treatments. Each year, sickle cell disease afflicts about 100,000 babies, primarily of African descent, who endure the painful debilitating condition caused by a mutant hemoglobin gene. Other members of the team included Catherine Brion, Mary Stevens, and Mohandas Narla.


Return to Top of Page

The electronic form of the newsletter may be cited in the following style:
Human Genome Program, U.S. Department of Energy, Human Genome News (v9n3).

Human Genome Project 1990–2003

The Human Genome Project (HGP) was an international 13-year effort, 1990 to 2003. Primary goals were to discover the complete set of human genes and make them accessible for further biological study, and determine the complete sequence of DNA bases in the human genome. See Timeline for more HGP history.

Human Genome News

Published from 1989 until 2002, this newsletter facilitated HGP communication, helped prevent duplication of research effort, and informed persons interested in genome research.